CA964192A - Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinone - Google Patents
Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinoneInfo
- Publication number
- CA964192A CA964192A CA118,245A CA118245A CA964192A CA 964192 A CA964192 A CA 964192A CA 118245 A CA118245 A CA 118245A CA 964192 A CA964192 A CA 964192A
- Authority
- CA
- Canada
- Prior art keywords
- dihydronormorphinone
- long
- formulations containing
- narcotic antagonist
- pamoate salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5697570A | 1970-07-21 | 1970-07-21 | |
US12033671A | 1971-03-02 | 1971-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA964192A true CA964192A (en) | 1975-03-11 |
Family
ID=26735916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA118,245A Expired CA964192A (en) | 1970-07-21 | 1971-07-14 | Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinone |
Country Status (3)
Country | Link |
---|---|
CA (1) | CA964192A (en) |
DE (1) | DE2135856A1 (en) |
FR (1) | FR2100936A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW225536B (en) * | 1990-08-23 | 1994-06-21 | Ciba Geigy Ag |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3215600A (en) * | 1962-06-29 | 1965-11-02 | Parke Davis & Co | Antimalarial composition containing an acylated sulfonylaniline with triazine or pyrimidine salt, and method of use |
-
1971
- 1971-07-14 CA CA118,245A patent/CA964192A/en not_active Expired
- 1971-07-17 DE DE19712135856 patent/DE2135856A1/de active Pending
- 1971-07-20 FR FR7126507A patent/FR2100936A1/en active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2100936B1 (en) | 1974-09-06 |
FR2100936A1 (en) | 1972-03-24 |
DE2135856A1 (en) | 1972-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA964193A (en) | Injectable compositions containing salts of l-tetramisole | |
CA942116A (en) | Rake head | |
CA1005342A (en) | Pharmaceutical composition containing nicotinic acid derivatives | |
CY678A (en) | Pharmaceutical compositions containing ergot alkaloids | |
CA964192A (en) | Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinone | |
CA938294A (en) | Manufacture of 1,1'-disubstituted-4,4'-bipyridylium salts | |
IE37847L (en) | Preparation of alkyl carbonates | |
IL43609A0 (en) | Pharmaceutical compositions containing salts of sulfoglycopeptides with amino-acids | |
CA939353A (en) | Manufacture of 1,1'-disubstituted-4,4'-bipyridylium salts and related compounds | |
CA966111A (en) | Stable solutions of basic lead salts | |
CA933149A (en) | Basic 17-aza-steroids and salts thereof and preparation of these compounds | |
IL37623A0 (en) | Theophylline isobutyrate salts,their preparation and pharmaceutical compositions containing them | |
CA853673A (en) | Pharmaceutical compositions containing ergot alkaloids | |
CA951491A (en) | Preparation of lead compounds | |
CA837127A (en) | Preparation of propenylphosphonic acid compounds | |
CA775039A (en) | Preparation of basic salts | |
AU414057B2 (en) | Pharmaceutical compositions containing ergot alkaloids | |
AU2294367A (en) | Acid addition salts of 2 substituted benzimidazoles | |
AU415415B2 (en) | Cinchona alkaloid salts and compositions containing them | |
CA780903A (en) | Preparation of aminobiuret salts | |
AU438105B2 (en) | Method for preparation of dithiolium salts | |
AU445927B2 (en) | Derivatives of renzoic acnd their use as antinflamatory compounds | |
CA848983A (en) | Preparation of styryloxazole compounds | |
CA859773A (en) | Preparation of hexaaryldilead compounds | |
CA859202A (en) | Preparation of magnesium-alcohol compounds |